Patients with the 20 most deadly neoplasms in Poland have full access to only 29 out of 136 recommended therapies. Another 46 cancer drugs are reimbursed with limitations. The National Health Fund will not pay for the treatment of the rest - according to the data on the Onkoindex website.
Oncofundacja Alivia is investigating how many therapies recommended by the European Society of Clinical Oncology (ESMO) can be used by Polish patients free of charge. The level of accessibility to therapy is determined by the Oncoindex index, which can range from 0 to 100 points. 0 is a total...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
